Global Asthma Immunotherapies Market Size, Status and Forecast 2021-2027
SKU ID :QYR-17716198 | Published Date: 18-Mar-2021 | No. of pages: 98Description
TOC
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Asthma Immunotherapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
1.3 Market by Application
1.3.1 Global Asthma Immunotherapies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Asthma Immunotherapies Market Perspective (2016-2027)
2.2 Asthma Immunotherapies Growth Trends by Regions
2.2.1 Asthma Immunotherapies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Asthma Immunotherapies Historic Market Share by Regions (2016-2021)
2.2.3 Asthma Immunotherapies Forecasted Market Size by Regions (2022-2027)
2.3 Asthma Immunotherapies Industry Dynamic
2.3.1 Asthma Immunotherapies Market Trends
2.3.2 Asthma Immunotherapies Market Drivers
2.3.3 Asthma Immunotherapies Market Challenges
2.3.4 Asthma Immunotherapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Asthma Immunotherapies Players by Revenue
3.1.1 Global Top Asthma Immunotherapies Players by Revenue (2016-2021)
3.1.2 Global Asthma Immunotherapies Revenue Market Share by Players (2016-2021)
3.2 Global Asthma Immunotherapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Asthma Immunotherapies Revenue
3.4 Global Asthma Immunotherapies Market Concentration Ratio
3.4.1 Global Asthma Immunotherapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Asthma Immunotherapies Revenue in 2020
3.5 Asthma Immunotherapies Key Players Head office and Area Served
3.6 Key Players Asthma Immunotherapies Product Solution and Service
3.7 Date of Enter into Asthma Immunotherapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Asthma Immunotherapies Breakdown Data by Type
4.1 Global Asthma Immunotherapies Historic Market Size by Type (2016-2021)
4.2 Global Asthma Immunotherapies Forecasted Market Size by Type (2022-2027)
5 Asthma Immunotherapies Breakdown Data by Application
5.1 Global Asthma Immunotherapies Historic Market Size by Application (2016-2021)
5.2 Global Asthma Immunotherapies Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Asthma Immunotherapies Market Size (2016-2027)
6.2 North America Asthma Immunotherapies Market Size by Type
6.2.1 North America Asthma Immunotherapies Market Size by Type (2016-2021)
6.2.2 North America Asthma Immunotherapies Market Size by Type (2022-2027)
6.2.3 North America Asthma Immunotherapies Market Size by Type (2016-2027)
6.3 North America Asthma Immunotherapies Market Size by Application
6.3.1 North America Asthma Immunotherapies Market Size by Application (2016-2021)
6.3.2 North America Asthma Immunotherapies Market Size by Application (2022-2027)
6.3.3 North America Asthma Immunotherapies Market Size by Application (2016-2027)
6.4 North America Asthma Immunotherapies Market Size by Country
6.4.1 North America Asthma Immunotherapies Market Size by Country (2016-2021)
6.4.2 North America Asthma Immunotherapies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Asthma Immunotherapies Market Size (2016-2027)
7.2 Europe Asthma Immunotherapies Market Size by Type
7.2.1 Europe Asthma Immunotherapies Market Size by Type (2016-2021)
7.2.2 Europe Asthma Immunotherapies Market Size by Type (2022-2027)
7.2.3 Europe Asthma Immunotherapies Market Size by Type (2016-2027)
7.3 Europe Asthma Immunotherapies Market Size by Application
7.3.1 Europe Asthma Immunotherapies Market Size by Application (2016-2021)
7.3.2 Europe Asthma Immunotherapies Market Size by Application (2022-2027)
7.3.3 Europe Asthma Immunotherapies Market Size by Application (2016-2027)
7.4 Europe Asthma Immunotherapies Market Size by Country
7.4.1 Europe Asthma Immunotherapies Market Size by Country (2016-2021)
7.4.2 Europe Asthma Immunotherapies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Asthma Immunotherapies Market Size (2016-2027)
8.2 Asia-Pacific Asthma Immunotherapies Market Size by Type
8.2.1 Asia-Pacific Asthma Immunotherapies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Asthma Immunotherapies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Asthma Immunotherapies Market Size by Type (2016-2027)
8.3 Asia-Pacific Asthma Immunotherapies Market Size by Application
8.3.1 Asia-Pacific Asthma Immunotherapies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Asthma Immunotherapies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Asthma Immunotherapies Market Size by Application (2016-2027)
8.4 Asia-Pacific Asthma Immunotherapies Market Size by Region
8.4.1 Asia-Pacific Asthma Immunotherapies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Asthma Immunotherapies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Asthma Immunotherapies Market Size (2016-2027)
9.2 Latin America Asthma Immunotherapies Market Size by Type
9.2.1 Latin America Asthma Immunotherapies Market Size by Type (2016-2021)
9.2.2 Latin America Asthma Immunotherapies Market Size by Type (2022-2027)
9.2.3 Latin America Asthma Immunotherapies Market Size by Type (2016-2027)
9.3 Latin America Asthma Immunotherapies Market Size by Application
9.3.1 Latin America Asthma Immunotherapies Market Size by Application (2016-2021)
9.3.2 Latin America Asthma Immunotherapies Market Size by Application (2022-2027)
9.3.3 Latin America Asthma Immunotherapies Market Size by Application (2016-2027)
9.4 Latin America Asthma Immunotherapies Market Size by Country
9.4.1 Latin America Asthma Immunotherapies Market Size by Country (2016-2021)
9.4.2 Latin America Asthma Immunotherapies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Asthma Immunotherapies Market Size (2016-2027)
10.2 Middle East & Africa Asthma Immunotherapies Market Size by Type
10.2.1 Middle East & Africa Asthma Immunotherapies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Asthma Immunotherapies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Asthma Immunotherapies Market Size by Type (2016-2027)
10.3 Middle East & Africa Asthma Immunotherapies Market Size by Application
10.3.1 Middle East & Africa Asthma Immunotherapies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Asthma Immunotherapies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Asthma Immunotherapies Market Size by Application (2016-2027)
10.4 Middle East & Africa Asthma Immunotherapies Market Size by Country
10.4.1 Middle East & Africa Asthma Immunotherapies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Asthma Immunotherapies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Anergis
11.1.1 Anergis Company Details
11.1.2 Anergis Business Overview
11.1.3 Anergis Asthma Immunotherapies Introduction
11.1.4 Anergis Revenue in Asthma Immunotherapies Business (2016-2021)
11.1.5 Anergis Recent Development
11.2 HAL Allergy Group
11.2.1 HAL Allergy Group Company Details
11.2.2 HAL Allergy Group Business Overview
11.2.3 HAL Allergy Group Asthma Immunotherapies Introduction
11.2.4 HAL Allergy Group Revenue in Asthma Immunotherapies Business (2016-2021)
11.2.5 HAL Allergy Group Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Asthma Immunotherapies Introduction
11.3.4 Merck Revenue in Asthma Immunotherapies Business (2016-2021)
11.3.5 Merck Recent Development
11.4 ALK-Abello
11.4.1 ALK-Abello Company Details
11.4.2 ALK-Abello Business Overview
11.4.3 ALK-Abello Asthma Immunotherapies Introduction
11.4.4 ALK-Abello Revenue in Asthma Immunotherapies Business (2016-2021)
11.4.5 ALK-Abello Recent Development
11.5 Stallergenes Greer
11.5.1 Stallergenes Greer Company Details
11.5.2 Stallergenes Greer Business Overview
11.5.3 Stallergenes Greer Asthma Immunotherapies Introduction
11.5.4 Stallergenes Greer Revenue in Asthma Immunotherapies Business (2016-2021)
11.5.5 Stallergenes Greer Recent Development
11.6 Laboratorios LETI
11.6.1 Laboratorios LETI Company Details
11.6.2 Laboratorios LETI Business Overview
11.6.3 Laboratorios LETI Asthma Immunotherapies Introduction
11.6.4 Laboratorios LETI Revenue in Asthma Immunotherapies Business (2016-2021)
11.6.5 Laboratorios LETI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Tables & Figures
List of Tables
Table 1. Global Asthma Immunotherapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Subcutaneous Immunotherapy
Table 3. Key Players of Sublingual Immunotherapy
Table 4. Global Asthma Immunotherapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Asthma Immunotherapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Asthma Immunotherapies Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Asthma Immunotherapies Market Share by Regions (2016-2021)
Table 8. Global Asthma Immunotherapies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Asthma Immunotherapies Market Share by Regions (2022-2027)
Table 10. Asthma Immunotherapies Market Trends
Table 11. Asthma Immunotherapies Market Drivers
Table 12. Asthma Immunotherapies Market Challenges
Table 13. Asthma Immunotherapies Market Restraints
Table 14. Global Asthma Immunotherapies Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Asthma Immunotherapies Market Share by Players (2016-2021)
Table 16. Global Top Asthma Immunotherapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Asthma Immunotherapies as of 2020)
Table 17. Ranking of Global Top Asthma Immunotherapies Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Asthma Immunotherapies Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Asthma Immunotherapies Product Solution and Service
Table 21. Date of Enter into Asthma Immunotherapies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Asthma Immunotherapies Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Asthma Immunotherapies Revenue Market Share by Type (2016-2021)
Table 25. Global Asthma Immunotherapies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Asthma Immunotherapies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Asthma Immunotherapies Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Asthma Immunotherapies Revenue Market Share by Application (2016-2021)
Table 29. Global Asthma Immunotherapies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Asthma Immunotherapies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Asthma Immunotherapies Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Asthma Immunotherapies Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Asthma Immunotherapies Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Asthma Immunotherapies Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Asthma Immunotherapies Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Asthma Immunotherapies Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Asthma Immunotherapies Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Asthma Immunotherapies Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Asthma Immunotherapies Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Asthma Immunotherapies Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Asthma Immunotherapies Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Asthma Immunotherapies Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Asthma Immunotherapies Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Asthma Immunotherapies Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Asthma Immunotherapies Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Asthma Immunotherapies Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Asthma Immunotherapies Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Asthma Immunotherapies Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Asthma Immunotherapies Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Asthma Immunotherapies Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Asthma Immunotherapies Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Asthma Immunotherapies Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Asthma Immunotherapies Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Asthma Immunotherapies Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Asthma Immunotherapies Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Asthma Immunotherapies Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Asthma Immunotherapies Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Asthma Immunotherapies Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Asthma Immunotherapies Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Asthma Immunotherapies Market Size by Country (2022-2027) & (US$ Million)
Table 61. Anergis Company Details
Table 62. Anergis Business Overview
Table 63. Anergis Asthma Immunotherapies Product
Table 64. Anergis Revenue in Asthma Immunotherapies Business (2016-2021) & (US$ Million)
Table 65. Anergis Recent Development
Table 66. HAL Allergy Group Company Details
Table 67. HAL Allergy Group Business Overview
Table 68. HAL Allergy Group Asthma Immunotherapies Product
Table 69. HAL Allergy Group Revenue in Asthma Immunotherapies Business (2016-2021) & (US$ Million)
Table 70. HAL Allergy Group Recent Development
Table 71. Merck Company Details
Table 72. Merck Business Overview
Table 73. Merck Asthma Immunotherapies Product
Table 74. Merck Revenue in Asthma Immunotherapies Business (2016-2021) & (US$ Million)
Table 75. Merck Recent Development
Table 76. ALK-Abello Company Details
Table 77. ALK-Abello Business Overview
Table 78. ALK-Abello Asthma Immunotherapies Product
Table 79. ALK-Abello Revenue in Asthma Immunotherapies Business (2016-2021) & (US$ Million)
Table 80. ALK-Abello Recent Development
Table 81. Stallergenes Greer Company Details
Table 82. Stallergenes Greer Business Overview
Table 83. Stallergenes Greer Asthma Immunotherapies Product
Table 84. Stallergenes Greer Revenue in Asthma Immunotherapies Business (2016-2021) & (US$ Million)
Table 85. Stallergenes Greer Recent Development
Table 86. Laboratorios LETI Company Details
Table 87. Laboratorios LETI Business Overview
Table 88. Laboratorios LETI Asthma Immunotherapies Product
Table 89. Laboratorios LETI Revenue in Asthma Immunotherapies Business (2016-2021) & (US$ Million)
Table 90. Laboratorios LETI Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Asthma Immunotherapies Market Share by Type: 2020 VS 2027
Figure 2. Subcutaneous Immunotherapy Features
Figure 3. Sublingual Immunotherapy Features
Figure 4. Global Asthma Immunotherapies Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Online Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Asthma Immunotherapies Report Years Considered
Figure 9. Global Asthma Immunotherapies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Asthma Immunotherapies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Asthma Immunotherapies Market Share by Regions: 2020 VS 2027
Figure 12. Global Asthma Immunotherapies Market Share by Regions (2022-2027)
Figure 13. Global Asthma Immunotherapies Market Share by Players in 2020
Figure 14. Global Top Asthma Immunotherapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Asthma Immunotherapies as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Asthma Immunotherapies Revenue in 2020
Figure 16. Global Asthma Immunotherapies Revenue Market Share by Type (2016-2021)
Figure 17. Global Asthma Immunotherapies Revenue Market Share by Type (2022-2027)
Figure 18. North America Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Asthma Immunotherapies Market Share by Type (2016-2027)
Figure 20. North America Asthma Immunotherapies Market Share by Application (2016-2027)
Figure 21. North America Asthma Immunotherapies Market Share by Country (2016-2027)
Figure 22. United States Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Asthma Immunotherapies Market Share by Type (2016-2027)
Figure 26. Europe Asthma Immunotherapies Market Share by Application (2016-2027)
Figure 27. Europe Asthma Immunotherapies Market Share by Country (2016-2027)
Figure 28. Germany Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Asthma Immunotherapies Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Asthma Immunotherapies Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Asthma Immunotherapies Market Share by Region (2016-2027)
Figure 38. China Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Asthma Immunotherapies Market Share by Type (2016-2027)
Figure 46. Latin America Asthma Immunotherapies Market Share by Application (2016-2027)
Figure 47. Latin America Asthma Immunotherapies Market Share by Country (2016-2027)
Figure 48. Mexico Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Asthma Immunotherapies Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Asthma Immunotherapies Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Asthma Immunotherapies Market Share by Country (2016-2027)
Figure 54. Turkey Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Asthma Immunotherapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Anergis Revenue Growth Rate in Asthma Immunotherapies Business (2016-2021)
Figure 58. HAL Allergy Group Revenue Growth Rate in Asthma Immunotherapies Business (2016-2021)
Figure 59. Merck Revenue Growth Rate in Asthma Immunotherapies Business (2016-2021)
Figure 60. ALK-Abello Revenue Growth Rate in Asthma Immunotherapies Business (2016-2021)
Figure 61. Stallergenes Greer Revenue Growth Rate in Asthma Immunotherapies Business (2016-2021)
Figure 62. Laboratorios LETI Revenue Growth Rate in Asthma Immunotherapies Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Companies
Anergis
HAL Allergy Group
Merck
ALK-Abello
Stallergenes Greer
Laboratorios LETI
- PRICE
-
$3900$7800$5850Buy Now